Skip to main content

BIO Names Kay Hagan Legislator of the Year


Senator Kay Hagan has earned praise for her work to get new potentially life-saving drugs to patients faster.

The Biotechnology Industry Organization gave Hagan one of its Legislator of the Year awards on Wednesday in Washington D.C.


Leaders, Entrepreneurs, Partners and More: Live Blog from #LSC2012

2:15 pm
A big thank you to the more than 950 people who made or annual celebration of life science a success. The team at CED had been a fantastic partner for this event for 21 years.


1:55 pm
Deborah Dunsire of Millennium echoes a phrase i've heard several times at this conference.

Inflection point.

Advice and info for startups at BIO 2011

Pappas Ventures' managing partner Arthur M. Pappas has some advice for startups today at BIO 2011 in Washington D.C.

The session topic is "Starting Up Biotechs in the New Normal." With talk at the Ernst and Young panel on Tuesday about doing more with less, Pappas and his fellow panel members will have valuable advice for those trying to make it in life sciences today.

The panel begins at 10 a.m.  in room 149 A/B.

Inside View: That's Me, NC

Laughter isn't something you typically hear in a board room. Ours had quite a bit Tuesday courtesy of a special guest.
We'd invited Kathy Proctor to join us for the meeting. We jokingly call her one of our poster children - she's a laid-off furniture worker who's getting a two-year biotech degree at Forsyth Tech. She embodies the promise we made nearly 30 years ago when the Center started creating a new  industry for the state.

Inside View: An AgBiotech View of the World

Editor's Note: The full roundtable discussion is featured in this month's Business North Carolina.

Every once in a while, I get the opportunity to listen to leaders in their fields discuss a topic. Late in January, the topic was agriculture, which might make you think about the food on your plate.

Then phrases like “protein-based diet versus starch-based diet” and “land and water use” started flying.

Targacept to Present at BIO CEO & Investor Conference

Targacept, a clinical-stage biopharmaceutical company developing a new class of drugs known as NNR Therapeutics, announced that J. Donald deBethizy, Ph.D., President and Chief Executive Officer, is scheduled to present at the 11th Annual BIO CEO and Investor Conference at the Waldorf-Astoria Hotel in New York City on Tuesday, February 10 at 11:00 a.m.

Pfizer's $68B Purchase of Wyeth Is North Carolina's Business

North Carolina's broad pharmaceutical base continued to absorb global changes in the industry with this week's $68 billion purchase of Wyeth by Pfizer -- the largest such combination since Glaxo Wellcome bought SmithKline Beecham for $76 billion in 2000.

Here are some of the ways North Carolina is affected:

* Wyeth employs about 1,000 people at a manufacturing plant in Sanford -- one of Wyeth's largest.

BASF, Monsanto Await FDA OK On Drought-Tolerant Corn

A jointly developed drought-tolerant corn from BASF Plant Science and Monsanto is being reviewed by the U.S. Food and Drug Administration (FDA) for regulatory clearance, according to the companies.

Monsanto has submitted the product to the FDA and, if approved, the firms expect to have it available to farmers within the next four or five years. The BASF unit's R&D facility is in Research Triangle Park.

GSK Submits RLS Drug to FDA

GlaxoSmithKline and XenoPort announced that GSK has resubmitted the New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) requesting approval of Solzira (gabapentin enacarbil) Extended Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome (RLS).


Subscribe to RSS - National